Influence of late treatment on how chronic myeloid leukemia responds to imatinib

ABSTRACT: INTRODUCTION: In Brazil, patients with chronic myeloid leukemia (CML) in the chronic phase were not given first-line imatinib treatment until 2008. Therefore, there was a long period of time between diagnosis and the initiation of imatinib therapy for many patients. This study aims to compare the major molecular remission (MMR) rates of early versus late imatinib therapy in chronic phase CML patients. METHODS: Between May 2002 and November 2007, 44 patients with chronic phase CML were treated with second-line imatinib therapy at the Hematology Unit of the Ophir Loyola Hospital (Belém, Pará, Brazil). BCR-ABL transcript levels were measured at approximately six-month intervals using quantitative polymerase chain reaction. RESULTS: The early treatment group presented a 60% probability of achieving MMR, while the probability for those patients who received late treatment was 40%. The probability of either not achieving MMR within one year of the initiation of imatinib therapy or losing MMR was higher in patients who received late treatment (79%), compared with patients who received early treatment (21%, odds ratio=5.75, P=0.012). The probability of maintaining MMR at 30 months of treatment was 80% in the early treatment group and 44% in the late treatment group (P=0.0005). CONCLUSIONS: For CML patients in the chronic phase who were treated with second-line imatinib therapy, the probability of achieving and maintaining MMR was higher in patients who received early treatment compared with those patients for whom the time interval between diagnosis and initiation of imatinib therapy was longer than one year.

Identification of duplicates of cassava accessions sampled on the North Region of Brazil using microsatellite markers

Duplicatas costumam ocorrer em bancos de germoplasma e a sua identificação é necessária para facilitar o manejo dos bancos ativos de germoplasma (BAGs) e diminuir custos de manutenção. O objetivo deste trabalho foi identificar duplicatas de mandioca determinadas previamente pela caracterização morfo-agronômica, em um BAG da Amazônia Oriental. Foram selecionados 36 acessos que se agrupavam em 13 grupos de similaridade morfo-agronômica para serem genotipados com 15 locos microssatélites. Todos os locos foram polimórficos, sendo obtidos 75 alelos, com média de cinco alelos por loco e H_E = 0,66. Foram encontrados 34 pares de genótipos que apresentaram perfis multilocos idênticos e a probabilidade de identidade genética foi de 1,1x10^-12 com probabilidade de exclusão de 99,9999%. Entre essas duplicatas, estão materiais coletados em épocas e locais diferentes, e com diferentes denominações e acessos com o mesmo nome coletados em diferentes locais e anos. O estudo identificou genótipos que vem sendo cultivados em diferentes locais e que vêm sendo mantidos pelos agricultores ao longo dos anos.